Evotec SE logo

Evotec SE

XTER:EVT (Germany)   Ordinary Shares
€ 18.41 (-0.99%) Dec 1
On watch
At Loss
P/B:
2.86
Market Cap:
€ 3.26B ($ 3.55B)
Enterprise V:
€ 3.23B ($ 3.51B)
Volume:
259.70K
Avg Vol (2M):
364.14K
Also Trade In:
Volume:
259.70K
At Loss
Avg Vol (2M):
364.14K

Business Description

Description
Evotec SE is a drug discovery partnership company providing solutions to pharmaceutical & biotechnology companies, academic institutions as well as foundations, and not-for-profit organizations. The company offers its services in the area of neuronal diseases, diabetes & its complications, pain, inflammation, oncology, infectious diseases, respiratory & fibrosis, rare disease, and women's health. Its business segments are EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone drug discovery services on a typical fee-for-service basis or integrated drug discovery collaborations. The EVT Innovate segment develops drug discovery programs and assets, both internally and through academic collaborations. The majority of its revenue is derived from the EVT Execute segment.
Name Current Vs Industry Vs History
Cash-To-Debt 1.05
Equity-to-Asset 0.51
Debt-to-Equity 0.52
Debt-to-EBITDA -9.89
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 1.93
Distress
Grey
Safe
Beneish M-Score -2.28
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 48.81
9-Day RSI 52.09
14-Day RSI 52.2
6-1 Month Momentum % -21.93
12-1 Month Momentum % -7.99

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.16
Quick Ratio 2.09
Cash Ratio 1.43
Days Inventory 25.93
Days Sales Outstanding 93.54
Days Payable 79.53

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -5.5
Shareholder Yield % -1.37

Financials (Next Earnings Date:2024-03-28 Est.)

XTER:EVT's 30-Y Financials
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014

Evotec SE Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 607.246
EPS (TTM) (€) -0.45
Beta 0.92
Volatility % 49.13
14-Day RSI 52.2
14-Day ATR (€) 0.716279
20-Day SMA (€) 18.21575
12-1 Month Momentum % -7.99
52-Week Range (€) 14.8 - 24.44
Shares Outstanding (Mil) 177.19

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Evotec SE Filings

Filing Date Document Date Form
No Filing Data

Evotec SE Stock Events

Event Date Price(€)
No Event Data

Evotec SE Frequently Asked Questions

What is Evotec SE(XTER:EVT)'s stock price today?
The current price of XTER:EVT is €18.41. The 52 week high of XTER:EVT is €24.44 and 52 week low is €14.80.
When is next earnings date of Evotec SE(XTER:EVT)?
The next earnings date of Evotec SE(XTER:EVT) is 2024-03-28 Est..
Does Evotec SE(XTER:EVT) pay dividends? If so, how much?
Evotec SE(XTER:EVT) does not pay dividend.

Press Release

Subject Date
No Press Release